Findings aid antiviral drug discovery
Many viral infections, such as the common cold, cause mild illnesses that the body’s immune system eventually defeats. But when viruses cause severe disease, doctors have few options for effective treatment.
Studying mice with a variety of viral infections, scientists at Washington University School of Medicine in St. Louis have demonstrated a way to dial up the body’s innate immune defenses while simultaneously attacking a protein that many viruses rely on to replicate.
The findings, published Oct. 19 in Nature Immunology, reveal previously unknown weapons in the body’s antiviral immune arsenal and provide guidelines for designing drugs that could be effective against a broad range of viruses. The strategy involves enhancing the body’s interferon signaling system, long understood to be a vital part of antiviral defenses.
“We’ve discovered a new component of the interferon system,” said senior author Michael J. Holtzman, MD, the Selma and Herman Seldin Professor of Medicine. “It does something that other components don’t do, and it works on both sides of the fence: It dials up the body’s internal genes that fight viruses, and it attacks viral proteins directly.”
Holtzman and lead author Yong Zhang, PhD, an instructor in pulmonary medicine, suspect that the researchers’ one-two punch against the virus may explain the large difference in survival rates between control mice and mice genetically engineered to have increased signaling in their interferon systems.
When infected with encephalomyocarditis virus, which causes severe damage to vital organs including the brain, heart and pancreas, 97 percent of the genetically engineered mice survived, compared with none of the control mice. Even when the concentration of the injected virus was increased 100-fold, 82 percent of the genetically altered mice survived. And at 100-fold lower concentrations, all genetically engineered mice survived the infection, compared with only 25-28 percent of the control mice.
Holtzman pointed out that past research by other groups has shown that increasing the amount of interferon directly results in some improvements in fighting viruses, but not to the same extent as the current work. In addition, more modest improvements shown by other investigators usually are accompanied by autoimmune problems resulting from the chronically activated immune response. Despite the strong antiviral immune response seen in the new study, Holtzman and his colleagues reported no evidence of autoimmune disease in these mice.
The Latest on: Antiviral immune response
via Google News
The Latest on: Antiviral immune response
- COVID-19, MIS-C & Kawasaki Disease Lead to the Same Immune Responseon May 18, 2022 at 9:16 pm
The world has quickly learned that the SARS-CoV-2 virus causes COVID-19. But it can also cause another disorder in children caused MIS-C. | Immunology ...
- NIAID announces antiviral drug development awardson May 18, 2022 at 12:39 pm
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $577 million to establish nine Antiviral Drug Discovery ...
- The Daily Biotech Pulse: Pfizer/BioNTech's COVID-19 Booster For Kids, Moderna Starts First African Trial Of mRNA HIV Vaccine, Tonix Extends COVID-19 Antiviral Research Pacton May 18, 2022 at 8:01 am
Recent findings from the Phase 1 trial IAVI G001 showed that vaccination with the HIV immunogen eOD-GT8 60mer as a recombinant protein safely induced the targeted immune responses in ... and testing ...
- Discovery Made On How To Reduce Severe Tissue Damage From Some Viral Infectionson May 18, 2022 at 3:43 am
Senior author Ali Ashkar said IFN is a well-known anti-viral signalling molecule released by the body’s cells that can trigger a powerful immune response against harmful viruses. “What we have found ...
- Researchers discover how Type I interferon stops the immune system 'going rogue' during viral infectionson May 17, 2022 at 4:58 pm
Senior author Ali Ashkar said IFN is a well-known anti-viral signaling molecule released by the body's cells that can trigger a powerful immune response against harmful viruses. What we have found is ...
- Type-I interferon stops immune system from 'going rogue' during viral infectionson May 17, 2022 at 1:52 pm
McMaster University researchers have found not only how some viral infections cause severe tissue damage, but also how to reduce that damage.
- Type-I interferon stops immune system ‘going rogue’ during viral infectionson May 17, 2022 at 11:48 am
Senior author Ali Ashkar said IFN is a well-known anti-viral signalling molecule released by the body's cells that can trigger a powerful immune response against harmful viruses. “What we have found ...
- Impact of cannabidiol on cellular innate immune responses to SARS-CoV-2 geneson May 16, 2022 at 5:00 pm
The authors reported that CBD augments the cellular antiviral response to Poly (I:C). The current study demonstrated that CBD enhances the antiviral innate immune response based on three SARS-CoV-2 ...
- The gut microbiota protects against viral infections by keeping the immune system alerton May 11, 2022 at 7:27 am
The microbiota is fundamental for health. But how these non-invasive microbes communicate with the rest of the body to influence host physiology is not fully understood. Researchers from Stockholm, ...
- Gut Microbiome Protects Us From Viral Infections by Keeping the Immune System Poisedon May 11, 2022 at 1:09 am
Release of bacterial DNA from the gut microbiome to host cells helps activate the innate immune pathway for DNA sensing, keeping the immune system poised in case of infection.
via Bing News